- UroToday Home
- Recent Abstracts
- Urologic Oncology
Prostate Cancer
α-Mangostin, a xanthone from mangosteen fruit, promotes cell cycle arrest in prostate cancer and decreases xenograft tumor growth - Abstract
February 2, 2012
Recurrent deletion of CHD1 in prostate cancer with relevance to cell invasiveness - Abstract
February 2, 2012
Meta-analysis demonstrates no association between p53 codon 72 polymorphism and prostate cancer risk - Abstract
February 2, 2012
The value of urinary prostate cancer gene 3 (PCA3) scores in predicting pathological features at radical prostatectomy - Abstract
February 1, 2012
Optimal baseline prostate-specific antigen level to distinguish risk of prostate cancer in healthy men between 40 and 69 years of age - Abstract
February 1, 2012
Treatment given near the end of life in castration-resistant prostate cancer - Abstract
February 1, 2012
Evaluation of clinical benefits achievable by using different optimization algorithms during real-time prostate brachytherapy - Abstract
February 1, 2012
Open vs. robotic-assisted radical prostatectomy: A single surgeon and pathologist comparison of pathologic and oncologic outcomes - Abstract
February 1, 2012
Intermittent androgen deprivation in advanced prostate cancer - A review - Abstract
February 1, 2012
Histone H2B ubiquitin ligases RNF20 and RNF40 in androgen signaling and prostate cancer cell growth - Abstract
February 1, 2012
Modeling a lethal prostate cancer variant with small-cell carcinoma features - Abstract
February 1, 2012
Research from the 2012 Genitourinary Cancers Symposium highlights new treatments, compares existing therapies for prostate cancer
February 1, 2012
Chemoprevention of prostate cancer: Myths and realities - Abstract
January 31, 2012
Targeted therapy in prostate cancer - Abstract
January 31, 2012